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Abstract

CANCER MORTALITY RISK, FINE PARTICULATE AIR POLLUTION, AND
SMOKING IN A LARGE, REPRESENTATIVE COHORT OF US ADULTS

Nathan C. Coleman
Economics Department
Bachelor of Arts

Purpose: Studies have indicated that air pollution and smoking are associated with
various types of mortality, including cancer. The current study utilizes a nationally
representative cohort to explore relationships between fine particulate matter (PM2.5)
exposure, smoking, and cancer mortality.
Methods: National Health Interview Survey and mortality follow-up data were
combined to create a study population of 635,539 individuals surveyed from 1987 to
2014. A sub-cohort of 341,665 never-smokers from the full cohort was also evaluated.
Individuals were assigned modeled PM2.5 exposure. Cox proportional hazard models
were utilized to estimate hazard ratios for cancer-specific mortality controlling for age,
sex, race, and other important characteristics.
Results: The risk of all cancer mortality was positively associated with PM2.5 (per
10 µg/m3 increase) in the full cohort (hazard ratio [HR] 1.15, 95% confidence interval
[CI] 1.08–1.22) and the never-smokers’ cohort (HR 1.19, 95% CI 1.06–1.33). PM2.5 morality associations were also observed for stomach, colorectal, liver, breast, cervix, and
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bladder, as well as Hodgkin lymphoma, non-Hodgkin lymphoma, and leukemia. After
adjusting for multiple comparisons, however, only the PM2.5 morality association with
lung cancer in the non-smoking cohort was statistically significant. Cigarette smoking
was statistically associated with mortality from lung, oral and oropharyngeal, esophageal,
colorectal, liver, bladder, laryngeal, leukemia and unspecified cancers, even with
adjustment for multiple testing.
Conclusions: Exposure to PM2.5 air pollution likely contributes to lung cancer
mortality and may be a risk factor for other cancer sites. Cigarette smoking has a much
larger and is associated with similar cancer-sites.
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INTRODUCTION
Empirical evidence indicates that exposure to fine particulate matter air pollution
(PM2.5, particles < 2.5 µm in aerodynamic diameter) contributes to burden of disease for
all-cause mortality [1], cardiopulmonary disease [2], and cancer [3]. Previous studies
have focused on the association between lung cancer and PM2.5 [4-6]; however, evidence
indicates that exposure to air pollution could contribute to chronic systemic inflammation
[7], oxidative stress [8], and DNA damage [9] in tissues other than lung. For example,
recent studies have found associations with PM2.5 and non-lung cancer-sites including
bladder, colorectal, and kidney [10], female organ cancers and breast [11], liver [12], and
stomach [13]. Unfortunately, these studies are limited in scope and number, and not fully
consistent in their findings.
The objective of the current study was to explore PM2.5-mortality associations
with cancer-site specific mortality among a large, nationally representative cohort of
adults residing in the United States. Additionally, this study compared the association of
cigarette smoking status and cancer-site specific mortality to PM2.5 and cancer-site
specific mortality. Cigarette smoke contributes to the development of lung, oral and
oropharyngeal, esophageal, stomach, colorectal, liver, pancreatic, laryngeal, cervical,
bladder, kidney cancers, and leukemia through inhalation of a complex mix of
carcinogenic particles [14]. This analysis explored if the PM2.5-mortality associations and
the smoking mortality associations are observed for similar cancer sites.
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METHODS
Study Subjects
This analysis used public National Health Interview Survey (NHIS) and National
Death Index data to construct a cohort of individuals aged 18-84 at the time of survey
living in the continental U.S, who completed the NHIS survey between 1987 and 2014 as
documented elsewhere [2]. Participants represented the civilian noninstitutionalized US
adult population. Participant responses were linked to the National Death Index for
mortality follow-up through 2015. In addition, restricted-use geographic data allowed for
the assignment of ambient pollution estimates at the census tract level.
Analyses were performed on two cohorts. The first cohort consisted of the
635,539 individuals (age range 18-84 yrs, mean age 45.3) and the second was a subset of
this group of 341,665 participants who self-reported as never-smokers (age range 18-84,
mean age 43.4). Both cohorts contained information on age, sex, race-ethnicity (NonHispanic white, Hispanic, Non-Hispanic black, or other), income buckets ($0-35,000,
$35,000-50,000, $50,000-75,000, or over $75,000), marital status (married, divorced,
separated, never married, or widowed), educational attainment (less than high school
grad, high school grad, some college, college grad, more than college grad), BMI,
smoking status (self-identified as current, former, or never smoker), census tract, ambient
pollution exposure, interview date, mortality status, and date of death.
Further information about the composition of the cohorts, including details
regarding the merging and harmonization of key variables, is provided elsewhere [2].
Procedures for informed consent and data collection and linkage of the NHIS files were
approved by the NCHS Ethics Review Board. Findings and conclusions of this research
12

are those of the authors and do not necessarily represent the views of the RDC, the
NCHS, the Environmental Protection Agency, or the Centers for Disease Control and
Prevention.
Pollution Concentration
Individuals were assigned air pollution exposure estimates based on their resident
census tract at the time of the survey, using year-2000 Census tracts for individuals
surveyed from 1987 through 2010 and year-2010 Census tracts for those surveyed from
2011 through 2014. In the baseline analysis, each study subject was assigned the average
estimated PM2.5 concentration from 1999 through 2015. To obtain a longer exposure
window from 1988-1999, mean PM2.5 / PM10 ratios for 1999-2003 were computed and
multiplied by the PM10 estimate for each census tract from 1988-1998 [2].
Documentation of air pollution estimates utilized in this study is located elsewhere [15].
The modeled air pollution data are publicly accessible at the Center for Air, Climate, &
Energy Solutions website (https://www.caces.us/).
Statistical Methods
Hazards ratios and 95% confidence intervals for cancer mortality risk associated
with a 10 µg/m3 increase in PM2.5 concentrations were estimated using Cox proportional
hazards models that accounted for the complex, stratified, multistage NHIS sample
design [16]. Estimates were computed using the SURVEYPHREG procedure in SAS
version 9.3 (SAS Institute, Cary, North Carolina). Analysis was performed on cancer-site
specific cases ICD-10 codes for lung (C33-C34), oral and oropharyngeal (C00-C14),
esophageal (C15), stomach (C16), colorectal (C18-C21), liver (C22), pancreatic (C25),
laryngeal (C32), melanoma (C43), breast (C50), cervical (C53), ovarian (C54-C55),
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uterine (C56), prostate (C61), kidney (C64-C65), bladder (C67), and brain cancer (C70C72) as well as Hodgkin lymphoma (C81), non-Hodgkin lymphoma (NHL) (C82-C85),
leukemia (C91-C95), multiple myeloma (C88, C90), and other unspecified cancers (C17,
C23-24, C26-C49, C51-52, C57-60, C62-63, C66, C68-C69, C73-C80, C97). All models
were adjusted for age-sex-race interactions (using indicators for 5-year age buckets) and
categorical variables for BMI, income, education, marital status, rural versus urban,
region, and survey year. In the full cohort, models were also adjusted for smoking status.
Hazards ratios and 95% confidence intervals for cancer mortality risk associated with
smoking status were also estimated. To account for multiple testing, adaptive Holms
adjusted p-values [17] were calculated.
Model sensitivity analysis was performed by estimating six additional models: 1)
A model using traditional basic Cox Proportional Hazards model (using the Proc PHREG
procedure in SAS version 9.3) and controlling for all combinations of 1-yr age groups,
sex and race-ethnicity by allowing them to have their own baseline hazard (by including
them in the STRATA statement). 2) Model 1 but with indicator variables for education,
income, marital status, BMI, and smoking status also added as covariates in the model. 3)
Model 2 with indicator variables for urban/rural, census region, and survey year also
added as covariates. 4) Model 3 with mean PM2.5 data back casted to 1988 (i.e. exposure
window of 1988-2015 rather than 1999-2015). 5) Model 3 using only survey years from
1999-2014. 6) Model 3 using the expanded cohort (all 1,599,329 NHIS participants from
1986-2014, including those without smoking or BMI data) and not controlling for
smoking status or BMI.
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RESULTS
Figure 1 illustrates the average PM2.5 concentrations from 1999-2015 across
census tracts in the United States. Table 1 presents summary statistics for both the full
and never-smokers’ cohort groups. Individual mean estimated ambient PM2.5 exposure
was 10.7 µg/m3 (standard deviation 2.4) in both the full cohort and never-smokers’
cohort. The table also contains the average estimated PM2.5 exposure for the levels of the
selected variables. Individual mean exposure is relatively consistent across varying factor
levels aside from race/ethnicity (greater in non-Hispanic Blacks), urban versus rural
(greater in urban areas), and census region (greater in the Midwest).

Figure 1. Average PM2.5 concentrations from 1999-2015 for census tracts in the US
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Table 1. Summary of baseline characteristics in the full and never-smoker’s cohort.
Variable

Full Cohort (No. = 635,539)

Never-Smokers’ Cohort (No. = 341,665)

%

Mean (SD) PM2.5

%

Mean (SD) PM2.5

Sex
Male
Female

44.5
55.5

10.7 (2.4)
10.6 (2.4)

38.6
61.4

10.7 (2.4)
10.8 (2.4)

Race/Ethnicity
Non-Hispanic White
Hispanic
Non-Hispanic Black
All other/unknown

67.5
14.1
14.0
4.4

10.3 (2.2)
11.2 (3.0)
11.7 (1.9)
11.0 (2.6)

61.4
17.6
15.4
5.6

10.3 (2.2)
11.3 (3.0)
11.7 (1.9)
11.1 (2.6)

Income (inflation adjusted to
2015)
$ 0-35,000
$ 35-50,000
$ 50-75,000
$ 75,000+

38.0
15.5
18.8
27.7

10.8 (2.4)
10.6 (2.4)
10.6 (2.4)
10.5 (2.3)

36.6
14.9
18.7
29.9

10.9 (2.4)
10.7 (2.4)
10.7 (2.4)
10.6 (2.3)

Marital Status
Married
Divorced
Separated
Never Married
Widowed

49.6
14.1
3.6
24.3
8.5

10.5 (2.4)
10.6 (2.4)
11.1 (2.4)
11.0 (2.3)
10.7 (2.3)

49.9
10.9
3.1
27.8
8.3

10.6 (2.4)
10.7 (2.4)
11.2 (2.4)
11.0 (2.4)
10.8 (2.3)

Education
< High School grad
High School grad
Some College
College grad
>College grad

18.6
30.4
27.1
15.0
8.9

11.1 (2.5)
10.6 (2.3)
10.5 (2.4)
10.6 (2.3)
10.6 (2.3)

16.8
27.1
27.2
18.1
10.9

11.2 (2.5)
10.7 (2.4)
10.6 (2.3)
10.6 (2.3)
10.6 (2.3)

Urban/Rural
Urban
Rural

77.6
22.4

11.0 (2.4)
9.6 (2.1)

79.4
20.6

11.0 (2.4)
9.6 (2.1)

Census Region
Northeast
Midwest
South
West

18.1
23.7
35.7
22.5

10.6 (1.9)
11.1 (1.7)
10.8 (1.7)
10.0 (3.6)

17.5
22.5
36.3
23.8

10.8 (1.9)
11.1 (1.9)
10.8 (1.7)
10.3 (3.7)

BMI
<20
20-25
25-30
30-35
>35

7.3
36.4
33.8
14.4
8.1

10.7 (2.3)
10.6 (2.4)
10.7 (2.4)
10.7 (2.4)
10.8 (2.3)

7.3
36.7
33.1
14..5
8.4

10.7 (2.3)
10.7 (2.4)
10.7 (2.4)
10.8 (2.4)
10.8 (2.3)

Smoking
Never
Current
Former

53.8
23.9
22.4

10.7 (2.4)
10.7 (2.3)
10.5 (2.4)

100
0
0

10.7 (2.4)
-
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Table 2 provides cancer-specific mortality hazard ratios (HRs) and 95%
confidence intervals (CIs) associated with 10 µg/m3 increased PM2.5 exposure in both the
full and never-smokers’ cohorts. Without adjustments for multiple testing, statistically
significant associations were observed in the full cohort for lung, stomach, colorectal,
breast, cervical, and bladder cancer, as well as Hodgkin lymphoma, NHL, and leukemia.
However, after adjusting for multiple comparisons, these associations were not
statistically significant.
Table 1. Estimated hazard ratios (95% CIs) associated with 10 µg/m3 increase of PM2.5
adjusted for age, sex, race/ethnicity, income, education, marital status, BMI, smoking (for
the full cohort), urban versus rural, census regions, and survey year. P-values adjusted
using the Holm’s method are also included for individual cancer types
Cancer Types

Full Cohort

Never-Smokers’ Cohort

No. of
Deaths

Hazard Ratio
(95% CI)

Holm’s
p-value

No. of
Deaths

Hazard Ratio
(95% CI)

Holm’s
p-value

All Cancer
Lung
Non-Lung
Digestive and Accessory
Oral and oropharyngeal
Esophageal
Stomach
Colorectal
Liver
Pancreas
Sex Specific Organs
Breast
Cervical
Ovarian
Uterine
Prostate
Urinary

26,453
7,420
19,033

1.15 (1.08 – 1.22) *
1.13 (1.00 – 1.26) *
1.15 (1.07 – 1.24) *

0.58
-

17,743
6,710
11,033

1.19 (1.06 – 1.33) *
1.73 (1.20 - 2.49) *†
1.15 (1.02 – 1.30) *

0.04
-

374
599
525
2,572
761
1,607

1.19 (0.74 – 1.91)
0.59 (0.38 – 0.90)
1.87 (1.20 – 2.91) *
1.29 (1.05 – 1.58) *
1.32 (0.94 – 1.85)
1.09 (0.83 – 1.44)

1
0.19
0.07
0.18
1
1

291
460
301
1,441
489
956

1.90 (0.65 – 5.54)
0.79 (0.32 – 1.96)
2.01 (1.01 – 3.98) *
1.26 (0.93 – 1.70)
2.18 (1.25 – 3.81) *
0.94 (0.63 – 1.38)

1
1
0.51
1
0.06
1

2,099
237
392
750
1,215

1.33 (1.08 – 1.64) *
1.77 (1.00 – 3.16) *
1.03 (0.69 – 1.53)
1.20 (0.73 – 1.96)
0.91 (0.68 – 1.22)

0.09
0.62
1
1
1

949
115
121
317
802

1.32 (1.00 – 1.75) *
2.41 (1.19 – 4.89) *
1.06 (0.60 – 1.86)
1.64 (0.94 – 2.88)
0.60 (0.39 – 0.93)

0.60
0.17
1
0.91
0.26

Kidney
Bladder
Lymphoid
Hodgkin lymphoma
NHL
Leukemia
Multiple Myeloma
Other Cancers
Laryngeal
Melanoma
Brain
Unspecified Cancers

603
589

0.98 (0.66 – 1.46)
1.48 (1.00 – 2.29) *

1
0.63

359
451

0.94 (0.48 – 1.84)
2.00 (0.83 – 4.84)

1
1

59
1,016
970
541

4.18 (1.20 – 14.60) *
1.48 (1.10 – 1.98) *
1.43 (1.05 – 1.97) *
0.99 (0.64 – 1.53)

0.30
0.11
0.31
1

31
558
564
270

6.21 (1.15 – 33.46) *
1.27 (0.81 – 2.01)
1.34 (0.76 – 2.33)
0.83 (0.45 – 1.54)

0.37
1
1
1

157
392
622
2,952

0.82 (0.34 – 1.96)
0.72 (0.39 – 1.33)
1.48 (0.96 – 2.29)
0.89 (0.74 – 1.07)

1
1
0.89
1

142
213
344
1,858

0.74 (0.02 – 25.03)
0.54 (0.19 – 1.58)
1.51 (0.84 – 2.70)
0.80 (0.60 – 1.07)

1
1
1
1

Note that a p-value of 1 indicates a value greater than 0.9999 as reported by SAS PROC MULTTEST.
* Significant at 95% confidence level using the unadjusted p-values
† Significant at 95% confidence level using Holm’s adjusted p-values
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In the never-smokers’ cohort, statistically significant associations between PM2.5
and mortality were found for Hodgkin lymphoma and lung, stomach, liver, breast, and
cervical cancers. Only lung cancer was statistically significant after adjusting for multiple
comparisons. Table S1 shows sensitivity analysis performed on the full cohort for lung,
stomach, colorectal, liver, cervical, breast, and bladder cancers as well as Hodgkin’s
Lymphoma, Non-Hodgkin’s Lymphoma, and Leukemia. The PM2.5-moratality
associations across the different cancer sites were reasonably insensitive to various
modeling choices, different exposure windows, and even using the expanded NHIS
cohort; this was especially true for lung, colorectal, liver, and breast cancers.
Table 3 provides HRs and 95% CIs associated with identifying as a current
smoker or former smoker and cancer-site specific mortality in the full cohort. Statistically
significant smoking-cancer mortality HRs for current smokers were found for lung, oral
and oropharyngeal, esophageal, stomach, colorectal, liver, pancreatic, cervical, prostate,
kidney, bladder, laryngeal, brain, and unspecified cancers as well as leukemia. For former
smokers, statistically significant associations were found for lung, oral and
oropharyngeal, esophageal, colorectal, liver, breast, bladder, laryngeal, and unspecified
cancers as well as NHL and leukemia. Multiple comparison adjusted p-values were also
calculated, which resulted in statistically significant associations for lung, oral and
oropharyngeal, esophageal, stomach, colorectal, liver, pancreatic, cervical, bladder,
laryngeal, and unspecified cancers in current smokers and lung, oral and oropharyngeal,
esophageal, colorectal, liver, pancreatic, bladder, laryngeal, and unspecified cancers in
former smokers.

18

Table 3. Estimated hazard ratios (95% CIs) associated with current or former smoker in
comparison to never-smoker. All models were adjusted for age, sex, race, income,
education, marital status, BMI, urban versus rural, census regions, survey year, and a 10
µg/m3 increase of PM2.5. P-values adjusted using the Holm’s method are also included
for individual cancer types.
Current Smoker
Cancer Types

No. of
Deaths

All Cancer
Lung
Non-Lung
Digestive and
Accessory
Oral and oropharyngeal
Esophageal
Stomach
Colorectal
Liver
Pancreas
Sex Specific Organs
Breast
Cervical
Ovarian
Uterine
Prostate
Urinary
Kidney
Bladder
Lymphoid
Hodgkin lymphoma
NHL
Leukemia
Multiple Myeloma
Other Cancers
Laryngeal
Melanoma
Brain
Unspecified Cancers

Former Smoker

Hazard Ratio
(95% CI)

Holm’s
p-value

26,453
7,420
19,033

2.73 (2.64 – 2.83) *
15.11 (13.70 – 16.66) *†
1.59 (1.53 – 1.66) *

<0.01
-

374
599
525
2,572
761
1,607

4.84 (3.65 – 6.42) *†
3.25 (2.58 – 4.10) *†
1.74 (1.28 – 2.38) *†
1.37 (1.22 – 1.55) *†
2.09 (1.72 – 2.55) *†
2.04 (1.78 – 2.35) *†

2,099
237
392
750
1,215

No. of
Deaths

Hazard Ratio
(95% CI)

Holm’s
p-value

17,743
6,710
11,033

1.48 (1.43 – 1.53) *
4.90 (4.44 – 5.42) *†
1.18 (1.13 – 1.22) *

<0.01
-

<0.01
<0.01
<0.01
<0.01
<0.01
<0.01

291
460
301
1,441
489
956

1.66 (1.21 – 2.27) *†
1.67 (1.32 – 2.12) *†
1.15 (0.91 – 1.45)
1.23 (1.12 – 1.35) *†
1.45 (1.20 – 1.75) *†
1.14 (0.99 – 1.32)

0.02
<0.01
1
<0.01
<0.01
0.74

1.11 (0.99 – 1.26)
1.53 (1.13 – 2.08) *†
0.97 (0.79 – 1.18)
0.68 (0.50 – 0.93)
1.27 (1.05 – 1.54) *

0.40
0.04
1
0.02
0.09

949
115
121
317
802

1.12 (1.00 – 1.27)
1.04 (0.70 – 1.53)
1.05 (0.87 – 1.27)
0.65 (0.48 – 0.87)
0.99 (0.86 – 1.14)

0.62
1
1
0.20
1

603
589

1.34 (1.06 – 1.69) *
4.08 (3.20 – 5.20) *†

0.09
<0.01

359
451

1.10 (0.90 – 1.35)
2.39 (1.89 – 3.01) *†

1
<0.01

59
1,016
970
541

0.94 (0.45 – 1.96)
1.13 (0.93 – 1.37)
1.23 (1.01 – 1.52) *
0.76 (0.58 – 0.99)

1
0.82
0.27
0.27

31
558
564
270

1.04 (0.51 – 2.09)
1.18 (1.01 – 1.38) *
1.24 (1.04 – 1.47) *
0.95 (0.76 – 1.18)

1
0.48
0.19
1

157
392
622
2,952

10.27 (5.45 – 19.36) *†
1.01 (0.76 – 1.33)
1.37 (1.07 – 1.74) *
2.14 (1.93 – 2.38) *†

<0.01
1
0.07
<0.01

142
213
344
1,858

3.04 (1.46 – 6.32) *†
0.99 (0.77 – 1.28)
1.03 (0.83 – 1.27)
1.27 (1.16 – 1.39) *†

0.04
1
1
<0.01

Note that a p-value of 1 indicates a value greater than 0.9999 as reported by SAS PROC MULTTEST.
* Significant at 95% confidence level using the unadjusted p-values
† Significant at 95% confidence level using Holm’s adjusted p-values
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DISCUSSION
Consistent with a growing body of literature, this study provides evidence that
cancer mortality is associated with PM2.5 exposure in both smokers and never-smokers.
Analysis of the full cohort resulted in a hazard ratio of 1.15 (95% confidence interval of
1.08–1.22), which was comparable to that of the never-smokers’ cohort (HR 1.19, 95%
CI: 1.06–1.33). The result was comparable to a cohort that used 18.9 million Medicare
beneficiaries (HR 1.11, 95% CI: 1.09-1.12) [32]. Analysis of the full cohort for non-lung
cancers resulted in a hazard ratio of 1.15(95% CI: 1.07-1.24) which was also comparable
to the cohort of never-smokers’ (HR 1.15, 95% CI: 1.02-1.30). The results for non-lung
cancer are much larger than other cohort studies like the Harvard Six Cities Study (HR
1.04, 95% CI: 0.86-1.26) [33], the ACS study (HR 1.06, 95% CI: 1.00-1.129) [33], but
not statistically different.
Furthermore, this study provides strong evidence that lung cancer is likely the
primary driver of the association between cancer mortality and PM2.5. The study found a
hazard ratio of 1.13 (95% CI: 1.00-2.60) in the full cohort and a hazard ratio of 1.73
(95% CI: 1.20-2.49) in the never-smokers cohort, which was significant even after
multiple comparison adjustment. The PM2.5-lung cancer mortality hazard ratio was higher
in the never-smokers’ cohort than the in full cohort. The larger hazard ratio may be due to
a lower baseline mortality risk for lung cancer among never-smokers or a limited sample
size. The results from this study are comparable to a recent meta-analysis of cohorts
examining PM2.5-lung cancer mortality (HR 1.13, 95% CI: 1.07-1.20) [34].
The association between PM2.5 and mortality due to non-lung cancers is less clear.
Although the study did identify several cancer types (stomach, colorectal, liver, breast,
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cervical, and bladder cancers and Hodgkin’s lymphoma, NHL, and leukemia) that were
associated with PM2.5 exposure, none were statistically significant after adjusting for
multiple comparisons. Other studies have reported PM2.5-mortaltiy associations with
other cancers, including multiple studies for stomach cancer [10-11,13], colorectal cancer
[10-11], liver cancer [10-12,18-20], breast cancer [10-11,21-29], cervical cancer [10-11],
and bladder cancer [10-11,30-31]. Comparisons of the estimated hazard ratios, risk ratios,
incident rate ratios, and odds ratios (with their associated confidence intervals) for these
cancers are succinctly illustrated in Figure 2. Although there is substantial heterogeneity
across study estimates, the results of this study provide additional evidence to the
growing body of literature that PM2.5 exposure is associated with cancer mortality for
lung and some non-lung cancers.
The results are also consistent with existing literature on the relationship between
smoking and cancer [14], finding statistically significant associations after multiple
testing adjustment for lung, oral and oropharyngeal, esophageal, stomach, colorectal,
liver, pancreatic, laryngeal, cervical, kidney, bladder, and unspecified cancers. With the
exception of Hodgkin’s and non-Hodgkin’s lymphoma, cancer sites that were statistically
associated with PM2.5 in either cohort were also associated with smoking status. This
study also provides moderate evidence for the formal establishment of prostate, breast,
and unspecified cancers as caused by smoking [35]., cigarette smoking and PM2.5
exposure may both be risk factors, with cigarette smoking having a larger impact. Further
research is needed to determine the relationship between PM2.5, smoking, and cancer-site
mortality.
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Figure 2. Illustration of the comparison between the Hazard Ratio and 95% CI of full
cohort of the current study and hazard ratios [10-13,18,20,22-29,31], risk ratios [21],
incident rate ratios [19], and odds ratios [30] of other similar studies that estimated the
association between a 10 µg/m3 increase of PM2.5 and various cancer sites. The Wong et
al 2016 study includes esophageal cancer in its evaluation of stomach cancer, pancreatic
with liver cancer, ovarian and uterine with cervical cancer, and kidney with bladder
cancer.

A limitation of this study is the inability to directly measure exposure to ambient
air pollution over a lifetime. With extensive follow-up and advanced ground-based
monitoring and related modeling, this study used direct exposure estimates from 199922

2015. However, it does not directly account for exposure before this period. Although
back casted estimates of PM2.5 exposure and only including individuals surveyed after
1999 are similar to the original model, the estimates of the hazard ratios may still be
biased. Another limitation is the inability to control for migration. The migration problem
is further exacerbated by the long latency period of some cancer types. In future studies,
cancer incidence data could be used to reduce the latency concern. Additionally, this
study did not control for other pollutants such as NO2, SO2, or CO. Other studies have
found associations between pollutants other than PM2.5 and incidence and mortality from
various cancers [4, 36-37]. Future studies should control for these pollutants.
Another limitation of the study is the potential of residual confounding. The study
was unable to control for several important variables such as secondhand smoke, HPV
status, occupational exposure, hormonal therapy, oral contraceptive use, menopausal
status, alcohol consumption, dietary patterns, and genetic variables that are associated
with some cancer types. However, most cancer types were not sensitive to individual risk
factors such as age, sex, race and ethnicity, education, income, geographic variables, and
survey years, which suggests negligible risk of residual confounding. Furthermore,
average air pollution was generally consistent across the factor levels for the individual
risk factors, which suggests air pollution is less likely to be correlated with other omitted
variables.
A final limitation is the lack of follow-up and quantitative measurements in the
smoking data. The lack of follow-up would likely bias the estimates for smoking
downwards because the number of smokers is decreasing in America. Future studies
should also include quantitative measurements for smoking such as packs per day or
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number of years smoking. Although these weaknesses may call the results of the current
smoking status-mortality analysis into question, many of the cancer types that were
associated with current smokers are also associated with former smokers, so the lack of
follow-up and number of years smoked is less concerning. Furthermore, PM2.5-cancer
associations were similar in the never-smokers’ cohort, which suggests little risk of bias.
This study has several important strengths. First, the study uses a cohort that is a
representative sample of US adults with high quality survey information. Second, the
cohort is large and contains many deaths for most cancer types. Third, the analysis can
control for individual risk factors for cancer such as smoking and BMI. Fourth, results
were generally not sensitive to cohort selection or modeling approaches. Fifth, the results
for the association between cancer and lung cancer mortality and PM2.5 were generally
comparable to previous literature. Sixth, air pollution estimates and most other analysis
variables are publicly available.
Exposure to PM2.5 air pollution is a risk factor for lung cancer mortality and a
possible risk factor in mortality for various other cancer types. This analysis confirms
previous literature that cigarette smoking is associated with many cancer types. The
results from the current study and comparable studies suggest that PM2.5 may be
associated with stomach, colorectal, liver, breast and cervical cancer. All these cancers
were associated with smoking in the analysis. Although this exploratory study does not
provide definitive conclusions, the strength of the research design and the consistency of
results across modeling choices suggest further research is needed into the additional
biological pathways by which cancer in humans may be affected by PM2.5. The universal
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nature of pollution exposure, and its consequences, makes further study essential to
public health.
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APPENDIX 1
Table S1. Estimated hazard ratios (95% CIs) from sensitivity analysis performed on the
full cohort for statistically significant cancers in Table 2. The base model is a model
using traditional basic Cox Proportional Hazards model (using the Proc PHREG
procedure in SAS version 9.3) and controlling for all combinations of 1-yr age groups,
sex and race-ethnicity by allowing them to have their own baseline hazard (by including
them in the STRATA statement). The individual model is the base model, but with
indicator variables for education, income, marital status, BMI, and smoking status also
added as covariates in the model. The full model is the individual model, but with
indicator variables for urban/rural, census region, and survey year also added as
covariates. The back casted model is the full model, with mean PM2.5 data back casted to
1988 (i.e. exposure window of 1988-2015 rather than 1999-2015). The ≥1999 Survey
Years model is the full model, but only with survey years from 1999-2014. The expanded
cohort is the full model, but it uses the expanded cohort (all 1,599,329 NHIS participants
from 1986-2014, including those without smoking or BMI data) and not controlling for
smoking status or BMI.
Cancer
Lung
Stomach
Colorectal
Liver
Cervix
Breast
Bladder
Hodgkin
NHL
Leukemia

Traditional Model
Base

Individual

Full

Back casted

1.22 (1.10-1.35)
1.81 (1.24-2.63)
1.36 (1.14-1.61)
1.38 (1.02-1.87)
2.45 (1.42-4.22)
1.28 (1.06-1.55)
1.29 (0.90-1.84)
3.59 (1.22-10.56)
1.59 (1.21-2.08)
1.30 (0.98-1.72)

1.14 (1.03-1.26)
1.78 (1.22-2.58)
1.32 (1.11-1.57)
1.37 (1.01-1.85)
2.18 (1.26-3.78)
1.28 (1.06-1.55)
1.26 (0.88-1.80)
3.45 (1.18-10.08)
1.61 (1.22-2.11)
1.34 (1.01-1.77)

1.12 (1.00-1.25)
1.82 (1.24-2.69)
1.23 (1.02-1.47)
1.35 (0.99-1.84)
2.22 (1.27-3.88)
1.26 (1.03-1.54)
1.26 (0.86-1.84)
3.22 (1.05-9.86)
1.49 (1.12-1.98)
1.27 (0.94-1.71)

1.10 (1.00-1.20)
1.63 (1.20-2.22)
1.18 (1.02-1.36)
1.22 (0.95-1.56)
1.69 (1.09-2.63)
1.22 (1.04-1.43)
1.22 (0.91-1.65)
2.33 (0.96-5.67)
1.34 (1.07-1.68)
1.25 (0.99-1.58)

≥1999 Survey
Years
1.16 (0.95-1.41)
2.18 (1.10-4.33)
1.28 (0.92-1.77)
1.39 (0.89-2.17)
2.04 (0.80-5.24)
1.38 (0.97-1.96)
1.49 (0.80-2.78)
11.27 (1.45-87.79)
1.94 (1.18-3.18)
1.92 (1.17-3.15)

Expanded
Cohort
1.09 (1.02-1.17)
1.80 (1.45-2.24)
1.26 (1.12-1.41)
1.33 (1.10-1.60)
1.71 (1.20-2.44)
1.28 (1.13-1.45)
1.00 (0.79-1.27)
1.57 (0.78-3.14)
1.35 (1.14-1.61)
1.22 (1.02-1.46)
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